This educational activity has not been certified for Continuing Medical Education credit.

Activity Details

Released: May 19, 2020
Expires: May 18, 2023
60 minutes to complete

Provided By

Target Audience

Physicians and Nurses specific to cardiology care

Learning Objectives

  • Review the history of HCM
  • Review the epidemiology of HCM
  • Define HCM including the diagnostic criteria
  • Describe basic HCM genetics
  • Outline the clinical course for patients with HCM
  • Discuss the differential diagnosis for HCM

Activity Description

Hypertrophic Cardiomyopathy (HCM) is the most common form of genetically related cardiovascular disease. Moreover, It is the most common cause of sudden death in young people, particularly athletes. The purpose of this introductory webinar is to educate and engage clinicians, offering an overview of HCM in order to improve and optimize symptom recognition, in turn leading to earlier diagnosis and condition management.

Statement of Educational Need

Hypertrophic Cardiomyopathy (HCM) is the most common form of genetically related cardiovascular disease with an estimated prevalence ranging from 1 in 500 to 1 in 200 adults in the US. Therefore need exists to educate and engage clinicians and patients in order to improve and optimize HCM symptom recognition, earlier diagnosis and condition management, culminating in the need to bring a balanced message on the burden of HCM to the forefront for at-risk and diagnosed patients, caregivers and their healthcare providers.


5 minutes – Introduction
40 minutes – Slide Presentation of Hypertrophic Cardiomyopathy: An Introduction and Overview
10 minutes – Q & A
5 minutes – Closing Statement

Moderator: James E. Udelson, MD
Presenters: Sharon Cresci, MD, FAHA, FACC, FASE, & Robert Fraser, MD


James E. Udelson, MD
Chief, Division of Cardiology
Director, Nuclear Cardiology Laboratory
Tufts University School of Medicine
Boston, MA


Sharon Cresci, MD, FAHA, FACC, FASE
Associate Professor of Medicine
Associate Professor of Genetics
Director, IMPACT (Initiative for Mentoring, Promoting Networking
and Advocacy for Cardiology Trainees)
Director, Applied Genomics Core Laboratory for TRIUMPH
Washington University
Cardiovascular Division
St. Louis, MO

Robert Fraser, MD
Chief Cardiology Fellow
Hennepin Healthcare and Minneapolis Heart Institute
Minneapolis, MN

Planning Commmittee

Anjali Tiku Owens, MD
Assistant Prof. of Medicine
University of Pennsylvania
Philadelphia, PA

Stephanie Turrise, PhD, RN, BC, APRN, CNE
Assistant Professor
University of North Carolina, Wilmington
Wilmington, NC

Conflict of Interest Policy/Disclosure Statement

All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity.  In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations.  Such disclosures will be made in writing in course presentation materials.

The disclosures listed below represents the relationships of this educational activity’s faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content.

James E. Udelson, MD – Disclosures were not available
Sharon Cresci, MD, FAHA, FACC, FASE – No Disclosures
Robert Fraser, MD – No Disclosures
Anjali Tiku Owens, MD – MyoKardia: Research Grant
Stephanie Turrise, PhD, RN, BC, APRN, CNE – No Disclosures

Statement of Commercial Support

MyoKardia is a proud supporter of the American Heart Association.

Disclaimer Statement/Disclosure of Unlabeled Use

When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the faculty must disclose that the product is not labeled for the use under discussion or that the product is still investigational.

Contact Information for Questions About the Activity

Fred Porta
Program Manager, Lifelong Learning
AHA National Center

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.